Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

0
Player Avatar MissDookN (42.01) Submitted: 5/14/2007 11:19:53 PM : Outperform Start Price: $12.72 SLXP Score: +307.25

This stock meets my criteria for a long-term buy: great management and a good price.

Featured Broker Partners


Advertisement